Free shipping on all orders over $75 and curbside is available at all locations.

CBD Studies Database

At District Hemp Botanicals, we make it a priority to stay up-to-date on the latest CBD research and studies so that we can share that information with our customers. Each week, we scour news articles and read scientific journals to bring you scientifically-backed CBD studies and research. Click below to read detailed CBD research and studies from respected and trusted sources such as the U.S. National Library of Medicine at the National Institutes of Health, The Mayo Clinic, The FDA and more.

 

Click on any of the subjects to explore the database studies:

 

 

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review 
Summary: This study reviews human clinical studies that investigated the efficacy of CBD treatment for schizophrenia, substance use disorders, and their comorbidity.
Read the full study here.

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Summary: This paper provides an overview of preclinical animal and human clinical investigations, and presents preliminary clinical data that collectively sets a strong foundation in support of the further exploration of CBD as a therapeutic intervention against opioid relapse. 
Read the full study here

Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Summary: This study conducted a pilot, randomised double blind placebo controlled study set out to assess the impact of the as needed use of cannabidiol (CBD) in smokers who wished to stop smoking.
Read the full study here

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
Summary: This study’s goal is to summarize the available preclinical and clinical data on the impact of CBD on addictive behaviors.
Read the full study here

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Summary: This study’s goal is to evaluate the potential of CBD as an intervention for cocaine and methamphetamine addictive disorders.
Read the full study here.  

Cannabidiol (CBD) reduces cocaine-environment memory in mice
Summary: This study seeks to clarify the effects of CBD (10 mg/kg) on the acquisition, consolidation, reconsolidation, extinction and drug-primed reinstatement of cocaine (15 mg/kg) conditioned place preference (CPP) in adult male mice.
Read the full study here.

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Summary: This study investigated the potential of cannabidiol (CBD) to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder.
Read the full study here 

Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report
Summary: This case study illustrates the use of cannabidiol (CBD) oil to decrease the addictive use of marijuana and provide anxiolytic and sleep benefits.
Read the full study here.  

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Summary: This article seeks to review the role of the endocannabinoid system in substance use disorder and the proposed pharmacological action supporting cannabinoid drugs' therapeutic potential in addictions, with a focus on CBD. 
Read the full study here

US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions
Summary: This study used the Veterinary Information Network (VIN) to gauge US veterinarians' knowledge level, views and experiences related to the use of cannabinoids in the medical treatment of dogs.Most participants agreed that both marijuana and CBD products offer benefits for humans and expressed support for use of CBD products for animals.
Read the full study here

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
Summary: The objective of this study is to assess the safety and efficacy of cannabidiol (CBD) in dogs with osteoarthritis. Veterinary assessment showed decreased pain during CBD treatment.
Read the full study here

The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test
Summary: The purpose of this investigation was to evaluate the influence of CBD on behavioral responses to fear-inducing stimuli in dogs like fireworks.
Read the full study here

Cannabinoid treats as adjunctive therapy for pets: gaps in our knowledge
Summary: A literature search was conducted about the mechanism, efficacy, and safety of CBD pet treats in order to highlight the gaps in knowledge of CBD products and explain common misconceptions.
Read the full study here

Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
Summary: This study focuses on the use of cannabidiol (CBD)-rich hemp-based nutraceuticals in dogs and cats for disorders related to anxiety, seizures, cancer and pain. Based on these and other recent data, CBD-rich hemp nutraceuticals appear to be safe in healthy adult dogs, while more work in cats is needed to fully understand utility and absorption.
Read the full study here

Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs
Summary: The purpose of this study was to determine how cannabidiol moves throughout the body of healthy dogs using three different formulations of CBD.
Read the full study here

The Endocannabinoid System of Animals
Summary: This review article introduces the reader to the Endocannabinoid system in animals, and documents its potential as a source for emerging therapeutics for conditions such as pain management, cancer therapeutics, modulation of neurologic disorders, stress reduction, anxiety management, and inflammatory diseases.
Read the full study here

A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Summary: In this veterinary study, CBD significantly decreased pain and increased mobility in a dose-dependent fashion among animals with a confirmed diagnosis of osteoarthritis.
Read the full study here

Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy
Summary: This study assesses the effect of oral cannabidiol (CBD) administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with idiopathic epilepsy.
Read the full study here
 
CONSUMERS’ PERCEPTIONS OF HEMP PRODUCTS FOR ANIMALS
Summary: This study determined which hemp products pet owners are purchasing, reasons for their purchases, and the perceived value of these products on pets’ health.
Read the full study here

 

Cannabidiol as a Potential Treatment for Anxiety Disorders
Summary: Studies conducted in humans have shown that CBD has anxiety-reducing effects in acute dosing, and has considerable potential as a treatment for multiple anxiety disorders with long term use. 
Read the full study here.  

Use of Cannabidiol in Anxiety and Anxiety-Related Disorders
Summary: This study examined the safety and efficacy of CBD therapy in anxiety and anxiety-related disorders. In general, CBD was well-tolerated and associated with minimal adverse effects, with the most commonly noted adverse effects being fatigue and sedation.
Read the full study here    

Cannabidiol in Anxiety and Sleep: A Large Case Series 
Summary: A clinical case series conducted chart reviews in patients complaining of anxiety and poor sleep. Using cannabidiol (CBD) as an aid, sleep scores increased and anxiety scores decreased within a month in 100/103 patients.
Read the full study here.
 
Neural Basis of Anxiolytic Effects of Cannabidiol (CBD) in Generalized Social Anxiety Disorder: A Preliminary Report
Summary: A study was conducted to test the effects of cannabidiol (CBD) in patients with social anxiety disorder, and the results suggested that CBD reduced the effects of generalized social anxiety disorder.
Read the full study here.
 

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Summary: In this study, patients were given either CBD or a placebo before giving a public speech, and pretreatment with CBD significantly reduced anxiety, cognitive impairment and the patient's level of discomfort with public speaking, and and significantly decreased alertness in their anticipated speech.
Read the full study here.

 

 

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
Summary:This study was designed to evaluate the effects of cannabidiol on airway remodelling and the mechanisms of CB1 and CB2.
Read the full study here.

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Summary: This study’s aim is to evaluate the anti-inflammatory potential of cannabidiol through the lens of recognizing that T cell interaction with antigens/allergens is key to the development of inflammatory diseases.
Read the full study here

The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. 
Summary: This study investigates the effects of cannabidiol, a non-psychoactive component of cannabis for its actions on bronchial smooth muscle in vitro and in vivo.
Read the full study here

 

​​​​​​​

The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)
Summary: This study investigates the use of cannabidiol as a possible treatment for neurodevelopmental disorders such as Autism.
Read the full study here

Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use
Summary: This study tests the effectiveness of CBD for the treatment of autistic symptoms in refractory epilepsy patients. 
Read the full study here

Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Summary: This study looks at cannabidiol as a monotherapy or add-on treatment for the core symptoms and co-morbidities of ASD as well as summarizes the available pre-clinical and clinical data regarding the safety and effectiveness of CBD in young ASD patients.
Read the full study here

Autism Spectrum Disorder and Cannabidiol: Have We Seen This Movie Before?
Summary: This study identifies the current level of evidence for the safe and effective use of CBD with children diagnosed with ASD and provides guidance for clinicians who encounter this population of children and families. 
Read the full study here

Cannabinoid treatment for autism: a proof-of-concept randomized trial
Summary: A randomized controlled trial was conducted to test the outcome of two oral cannabinoid solutions on Autism Spectrum Disorder.
Read the full study here

Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Summary: This study examines real-life experiences of medical cannabis (30%CBD and 1-2% THC) treatment in autism. The study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD-rich oil derived from cannabis.
Read the full study here.  

CBD for Autism: The Therapeutic Promise
Summary: The Autism Society of America and Wholistic Research and Education Foundation have co-costed this educational webinar to discuss whether CBD indeed holds a therapeutic promise for autism and other neurodevelopmental disorders.
Read the full study here. 

Cannabis & Autism-- A Complex Pairing
Summary: This article defines Autism and how it interacts with the endocannabinoid system.
Read the full study here. 

Cannabidiol Based Medical Cannabis in Children with Autism- a Retrospective Feasibility Study
Summary: This study assesses safety, tolerability and efficacy of cannabidiol (CBD) based medical cannabis, as a secondary therapy, for refractory behavioral problems in children with ASD.
Read the full study here. 

Back to Top of Page Button

These studies provide insight into the effect that CBD has on cancer and people with cancer. These articles address different illnesses ranging from endometrial to breast cancer, among others, and have even shown promise in helping chemotherapy side effects. Read below to find out how CBD can help in the treatment of cancer. 

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
Summary: This study’s objective is to evaluate the effectiveness and tolerability of cannabis-based medications for chemotherapy-induced nausea and vomiting in adults with cancer.
Read the full study here

Cannabidiol in cancer treatment
Summary: This study’s objective was to test the Efficacy of pure CBD in various animal models as well as initial results (case reports) from patients.
Read the full study here.

Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Summary: The review is designed to provide an update regarding the multi-target effects of CBD in different types of cancer. The main focus is on the latest in vitro and in vivo studies that present data regarding the anti-proliferative, pro-apoptotic, cytotoxic, anti-invasive, anti-antiangiogenic, anti-inflammatory, and immunomodulatory properties of CBD together with their mechanisms of action. 
Read the full study here

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Summary: This review focuses on the mechanism of action of CBD and its potential applications in cancer therapy.
Read the full study here

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
Summary: This study aims to define the role of cannabidiol (CBD) in the management of symptom burden in patients with advanced cancer undergoing standard palliative care.
Read the full study here

Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy
Summary: This review deliberates the role of gold nanoparticle mediated PDT combined with CBD treatment on breast cancer cells.
Read the full study here

Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines
Summary:This study has examined the effect of CBD on two different human breast cancer cell lines: the ER-positive, well differentiated, T-47D and the triple negative, poor differentiated, MDA-MB-231 cells. 
Read the full study here

Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
Summary: This study compares the anti-proliferative effects of crude extract of Cannabis sativa and its main compound cannabidiol on different cervical cancer cell lines.
Read the full study here

The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
Summary: This study’s aim was to evaluate the expression of TRPV2 in biopsies and cell lines as well as the effects of CBD in in vitro models.
Read the full study here

Use of Cannabis and Cannabinoids in Patients With Cancer
Summary: This study’s objective is to review pharmacology, available dosage forms, efficacy, and safety of cannabis and cannabinoids in cancer patients.
Read the full study here.

 

 

Cannabinoids in Pediatrics
Summary: This study reviews the history of marijuana use and legislation in the United States in addition to the currently available medical literature in order to equip pediatric health care providers with resources to provide patients and their parents with the best recommendations for safe and appropriate use of cannabis-containing compounds.
Read the full study here
 
Examining cannabidiol use in children
Summary: This study examines the evidence relating to the safety and therapeutic benefit of CBD for pediatric patients, and offers suggestions as to how pediatricians should respond to inquiries from parents regarding its use.
Read the full study here. 
 
Medical cannabinoids may benefit children, long-term risks unclear
Summary: This study performed a systematic review of literature that included 21 articles detailing 22 studies with 795 participants in order to analyze the uses of cannabinoids to treat children.
Read the full study here. 
 
Use of cannabidiol oil in children
Summary: This study examines the effectiveness of cannabidiol in young children in the Netherlands for common reasons such as impulsive behavior, itchiness, epilepsy, stress, pain, and sleeping problems.
Read the full study here. 
 
The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children
Summary: This study investigates the therapeutic effects of CBD as well as its risks, quality standards, and labeling practices for children. 
Read the full study here. 
 
Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
Summary: This study reports interim results on the safety and efficacy of CBD in patients with treatment-resistant epilepsies in expanded access programs.
Read the full study here. 
 
A dose ranging safety and pharmacokinetic study of cannabidiol (CBD) in children with Dravet syndrome (GWPCARE1)
Summary: This controlled study evaluated dose-ranging safety, tolerability, and pharmacokinetics of supplemental CBD in children ages 4-10 with Dravet syndrome and then determined the dosage that assessed the safety and efficacy in a larger population.
Read the full study here. 
 
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study
Summary: This observational study evaluates the efficacy of CBD-enriched medical cannabis for the treatment of refractory epilepsy. According to parental reports, results suggest that adding CBD-enriched cannabis extract to the treatment regimen of patients with refractory epilepsy may result in a significant reduction in seizure frequency.
Read the full study here. 
 
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Summary: This study evaluates cannabidiol as a possible adjuvant treatment of refractory epilepsy in children testing drug-drug interactions with clobazam.
Read the full study here.

 

 

 

Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex

Summary: This study investigates whether CBD can induce rapid and sustained antidepressant-like effects after a single administration in male rodent and whether such effects could be related to changes in synaptic proteins and functions. Read the full study here.


Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa
Summary: This study’s aim is to review studies of animal models using CBD as an anxiolytic-like and antidepressant-like compound. Tests done in the studies found that CBD exhibited anti-anxiety and antidepressant effects in animal models discussed.
Read the full study here

Cannabidiol as a Treatment for Mood Disorders: A Systematic Review
Summary: This study’s purpose is to review the current evidence for efficacy of cannabidiol in the treatment of mood disorders. The inclusion criteria were clinical trials, observational studies, or case reports evaluating the effect of pure cannabidiol or cannabidiol mixed with other cannabinoids on mood symptoms related to either mood disorders or other health conditions.
Read the full study here
 
The therapeutic role of Cannabidiol in mental health: a systematic review
Summary: This study’s purpose is to summarize the clinical outcomes, study designs, and limitations for the use of CBD and nabiximols (whole plant extract from Cannabis sativa L. that has been purified into 1:1 ratio of CBD and delta-9-tetrahydrocannabinol) in the treatment of psychiatric disorders.
Read the full study here

Prohedonic Effect of Cannabidiol in a Rat Model of Depression
Summary: This study’s objective is to further examine these properties of CBD using the ‘depressive-like' Wistar-Kyoto (WKY) rat, focusing on the drug's effect on anhedonia-like (inability to feel pleasure) behaviors.
Read the full study here

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Summary: This study focuses on the anxiolytic, antidepressant, and antipsychotic effects of CBD found in animal and human studies. In rodents, results suggest that the effects of CBD depend on the dose, the strain, the administration time course (acute vs. chronic), and the route of administration.
Read the full study here

Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Summary: This study examines available evidence to ascertain the effectiveness and safety of all types of medicinal cannabinoids in treating symptoms of various mental disorders including depression, anxiety, attention-deficit hyperactivity disorder (ADHD), Tourette syndrome, post-traumatic stress disorder, and psychosis.
Read the full study here

Effects of cannabidiol in males and females in two different rat models of depression
Summary: This study explores the therapeutic potential of Cannabidiol using both sexes of 2 “depressive-like” genetic models, Wistar Kyoto (WKY) and Flinders Sensitive Line (FSL) rats. Findings suggest a role for CBD in treating mental disorders with prominent symptoms of helplessness and anhedonia.
Read the full study here.

 

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study
Summary: This study’s purpose is to determine whether CBD-enriched Cannabis extract is safe and well-tolerated for pediatric patients with refractory epilepsy and to monitor the effects of CBD-enriched Cannabis extract on the frequency and duration of seizure types and on quality of life.
Read the full study here.

Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps
Summary: This study researches CBD as a new therapeutic option to potentially fulfill the treatment gap in anti-seizure medications in epilepsy patients.
Read the full study here.

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Summary: This study evaluates the use of CBD, in addition to common anti-epileptic drugs, in the severe treatment-resistant epilepsy through an overview of recent literature and clinical trials aimed to study the effects of the CBD treatment in different forms of epilepsy. 
Read the full study here.

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Summary: This study’s purpose is to clarify the relative contribution of CBD to improved seizure outcomes in the trial data for the subgroup of patients not comedicated with clobazam.
Read the full study here.

Cannabidiol in the Treatment of Epilepsy
Summary: This study’s aim is to thoroughly review available research data and practical recommendations to provide the treating physician with the necessary information for counseling patients with epilepsy.
Read the full study here.

An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy
Summary: This study evaluates the effectiveness of add-on therapy with a standardized CBD-based oil in treatment-resistant epilepsy (TRE) patients.
Read the full study here.

A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy
Summary: This preliminary study examines whether daily CBD dose of 15–25 mg/kg produces cerebral macrostructure changes and, if present, how they relate to changes in seizure frequency.
Read the full study here.

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
Summary: This study reports interim results on the safety and efficacy of CBD in patients with treatment-resistant epilepsies in expanded access programs.
Read the full study here.

A dose ranging safety and pharmacokinetic study of cannabidiol (CBD) in children with Dravet syndrome (GWPCARE1)
Summary: This controlled study evaluated dose-ranging safety, tolerability, and pharmacokinetics of supplemental CBD in children ages 4-10 with Dravet syndrome and then determined the dosage that assessed the safety and efficacy in a larger population.
Read the full study here.

Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study
Summary: This observational study evaluates the efficacy of CBD-enriched medical cannabis for the treatment of refractory epilepsy. According to parental reports, results suggest that adding CBD-enriched cannabis extract to the treatment regimen of patients with refractory epilepsy may result in a significant reduction in seizure frequency.
Read the full study here.

Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Summary: This study evaluates cannabidiol as a possible adjuvant treatment of refractory epilepsy in children testing drug-drug interactions with clobazam.
Read the full study here.

 

A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
Summary: This study investigates the efficacy of Δ9-tetrahydrocannabinol/cannabidiol (THC/CBD) oromucosal spray, a novel cannabinoid formulation, in this 15-week randomized, double-blind, placebo-controlled parallel group study.
Read the full study here.
 
A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain
Summary: The long-term efficacy of delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray was investigated in this 38-week open-label extension study. 
Read the full study here.

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Summary: This study seeks to determine receptor mechanisms by which CBD inhibits CIPN and whether CBD negatively affects nervous system function or chemotherapy efficacy.
Read the full study here
 
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Summary: This study investigates cannabidiol’s effects on 5-HT neuronal activity, as well as its impact on models of neuropathic pain
Read the full study here

Single and combined effects of Δ9-tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain
Summary: This study tested the possible synergy between CBD and THC in decreasing mechanical sensitivity in a mouse model of paclitaxel-induced neuropathic pain. It also tested the effects of CBD on oxaliplatin- and vincristine-induced mechanical sensitivity.
Read the full study here.
 
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial
Summary: The purpose of this extension was to establish long-term tolerability and effectiveness profiles for THC/CBD oromucosal spray in CNP associated with multiple sclerosis.
Read the full study here.

The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
Summary: This study examined the efficacy of a topically delivered cannabidiol (CBD) oil in the management of neuropathic pain in this four-week, randomized and placebo-controlled trial.
Read the full study here.

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain Summary: This study investigated its therapeutic potential on neuropathic (sciatic nerve chronic constriction) and inflammatory pain (complete Freund's adjuvant intraplantar injection) in rats.  Read the full study here.

Cannabinoids for Neuropathic Pain
Summary: This article reviews the history, pharmacologic development, clinical trials results, and the future potential of non-smoked, orally bioavailable, non-psychoactive cannabinoids in the management of neuropathic pain.
Read the full study here.

The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review
Summary: To carry out a systematic review to assess the effectiveness of cannabis extracts and cannabinoids in the management of chronic nonmalignant neuropathic pain.
Read the full study here.

 

 

Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
Summary: This study aims to investigate the impact of full hemp extract cannabidiol (CBD) on opioid use and quality of life indicators among chronic pain patients.
Read the full study here 

CBD for Pain: Is Cannabidiol a Natural Alternative to Opioid Drugs? Summary: This study investigates CBD as a safe and natural alternative to opioids.
Read the full study here.  

Cannabidiol: Swinging the Marijuana Pendulum From ‘Weed’ to Medication to Treat the Opioid Epidemic
Summary: This study addresses the rapidly changing sociopolitical marijuana landscape and provides a foundation for the therapeutic development of medicinal cannabidiol to address the current opioid abuse crisis.
Read the full study here  

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis
Summary: This study’s aim was to conduct a systematic review to determine the opioid-sparing potential of cannabinoids.
Read the full study here.  

Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans
Summary: This study determines CBD safety and pharmacokinetics when administered concomitantly with a high-potency opioid in healthy subjects.
Read the full study here  

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
Summary: This study tests tolerance to cannabis and cannabis withdrawal symptoms and describes the case of a 19‐year‐old woman with cannabis withdrawal syndrome treated with cannabidiol (CBD) for 10 days.
Read the full study here  

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage 
Summary: This paper provides an overview of preclinical animal and human clinical investigations, and presents preliminary clinical data that collectively sets a strong foundation in support of the further exploration of CBD as a therapeutic intervention against opioid relapse. 
Read the full study here

 

Post traumatic stress disorder can occur after a trauma. Approximately 7-8% of the population experience PTSD at some point in their lives. Many studies have been conducted on the use and effectiveness of CBD as a therapeutic alternative treatment. The results thus far have been promising. Please find the full studies on CBD and PTSD below.  

Cannabinoids as therapeutic for PTSD

Summary: This review’s aim was to present an up-to-date look at current research on the possible therapeutic value of cannabinoids for PTSD. Experimental, preclinical, and clinical findings are discussed.

Read the full study here 

Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

Summary: This study examines the clinical benefit of CBD for patients with PTSD.

Read the full study here.  

Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials

Summary: This review’s goal was to highlight the potential of CBD as a treatment for disorders related to inappropriate retention of aversive memories, by assessing evidence from preclinical to human experimental studies.

Read the full study here. 

Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review

Summary: In this systematic review, the authors summarize the design and results of controlled trials assessing the effects of THC and CBD on affective disorders, anxiety disorders, and posttraumatic stress disorder (PTSD).

Read the full study here

Cannabinoid interventions for PTSD: Where to next?

Summary: This review presents an overview of recent research identifying neurological pathways by which different cannabinoid-based treatments may exert their effects on PTSD symptomology. 

Read the full study here 

The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A 

Systematic Review

Summary: This study sought to systematically review and assess the quality of the clinical evidence of the effectiveness of cannabinoids for the treatment of PTSD.

Read the full study here. 

Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review

Summary: This study reviews the extant knowledge on the effects of marijuana and other cannabinoids on PTSD. 

Read the full study here. 

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

Summary: This study reviews the current state of knowledge regarding the effects of cannabis and cannabinoids in PTSD and the preclinical and clinical literature on the effects of cannabinoids and endogenous cannabinoid signaling systems in the regulation of biological processes related to the pathogenesis of PTSD.

Read the full study here.

Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention

Summary: This article reviews the existing literature on the use of cannabinoids for treating and preventing PTSD in humans and animal models.

Read the full study here.

The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings

Summary: This review’s purpose is to offer a thorough overview of both animal and human studies investigating the effects of cannabinoids on memory processes.

Read the full study here.

 

FEMALE REPRODUCTIVE HEALTH

Cannabidiol (CBD) But Not Tetrahydrocannabinol (THC) Dysregulate in Vitro Decidualization of Human Endometrial Stromal Cells by Disruption of Estrogen Signaling 
Summary: This study investigates the effects of phytocannabinoids, CBD, and THC on decidualization. It was found that CBD impairs decidualization that may be associated with pregnancy-related disorders and infertility.

Read the full study here.
 
Dramatic Response to Laetrile and Cannabidiol (CBD) Oil in a Patient with Metastatic Low Grade Serous Ovarian Carcinoma
Summary: This study tested the effect of CBD oil on a patient with ovarian cancer combined with Laetrile.
Read the full study here

Cannabinoids and Reproduction: A Lasting and Intriguing History
Summary: This study focuses on the action of cannabinoids and endocannabinoids on the male and female reproductive tracts and the role they play in fertility.
Read the full study here
 
CBD & Cannabis for Endometriosis
Summary: Describes the effects that CBD has on endometriosis and provides real-life examples of women who have used CBD to help treat their endometriosis.
Read the full study here.
 
The Endocannabinoid Pathway and the Female Reproductive Organs
Summary: This study summarizes current knowledge of the effect of endocannabinoids in female reproductive organs.
Read the full study here.

The Endocannabinoid Anandamide Impairs in Vitro Decidualization of Human Cells
Summary: This study focuses on the effect of anandamide, a neurotransmitter, on decidualization and its impact on fertility.
Read the full study here. 

Is There a Role for Endocannabinoids in Sperm–Oviduct Interaction?
Summary: This study investigates the role of the endocannabinoid system has during sperm storage and release in the fallopian tubes of cattle.
Read the full study here.

Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis
Summary: This study believes adenomyosis, a complication that causes heavy bleeding and pain during menstruation, might be associated with lower levels of cannabinoid receptors in uterine tissue.
Read the full study here

MALE REPRODUCTIVE HEALTH

The Effects of Cannabidiol on Male Reproductive System: A Literature Review
Summary: This study tests the effect of CBD on the male reproductive system of humans, monkeys, mice, and rats. It concluded that CBD has possible negative effects on the reproductive system of males.
Read the full study here

Effects of Cannabinoids on Sperm Morphology
Summary: Mice’s sperm was tested after being treated with THC, CBD, CBN, and a control group. Those treated with CBD had sperm counts similar to the control while those treated with THC and CBN had abnormal sperm counts.
Read the full study here.

Is There a Role for Endocannabinoids in Sperm–Oviduct Interaction? 
Summary: The purpose of this study was to investigate whether or not the endocannabinoid system had a role during sperm storage and release in the fallopian tubes of cattle.
Read the full study here

Cannabinoids and Reproduction: A Lasting and Intriguing History
Summary: This study focuses on the action of cannabinoids and endocannabinoids on the male and female reproductive tracts and the role they play in fertility.
Read the full study here

The Role of Cannabinoids in Prostate Cancer: Basic Science Perspective and Potential Clinical Applications
Summary: This study reviews the effects of cannabinoids on prostate cancer and how prostate cancer cells interact with cannabinoid receptors 1 and 2.
Read the full study here.

Effects of Cannabinoids on Testosterone and Protein Synthesis in Rat Testis Leydig Cells in Vitro
Summary: This article studied the effect of cannabidiol on testosterone in rat testis and researchers found that CBD may inhibit testosterone production.
Read the full study here

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Summary: This study focuses on the pain relief benefit of CBD for benign prostatic hyperplasia, or an enlarged prostate.
Read the full study here

Cannabinoid Signalling and Effects of Cannabis on the Male Reproductive System
Summary: This article explores the effect of in vivo exposure to cannabinoids on the development of sperm.
Read the full study here

PREGNANCY 

Cannabinoid Exposure During Pregnancy and Its Impact on Immune Function
Summary: This study suggests that maternal exposure to CBD may dysregulate the immune system of the fetus and offspring leading to a weakened immune system later in life.
Read the full study here.

Endocannabinoid System and Pregnancy
Summary: This study suggests that alterations in the female endocannabinoid system while pregnant may lead to adverse pregnancy outcomes including miscarriage and comprimised placentation.
Read the full study here

 

 

The growing trend of cannabidiol in skincare products
Summary: This study investigates cannabidiol safety and efficacy as an ingredient in skincare products.

Read the full study here.  

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
Summary: This study explored the effects of the CBD on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent.

Read the full study here

Endocannabinoids Modulate Human Epidermal Keratinocyte Proliferation and Survival via the Sequential Engagement of Cannabinoid Receptor-1 and Transient Receptor Potential Vanilloid-1
Summary: This study examines whether the prototypic endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) has a role in growth and survival of epidermal keratinocytes.

Read the full study here

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Summary: This study investigates the balance of the endocannabinoid system and how it’s disruption might facilitate the development of multiple pathological conditions and diseases of the skin.

Read the full study here

Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System
Summary: This review’s aim is to give an overview of the available skin-relevant endo- and phytocannabinoid literature with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.

Read the full study here

Consumer interest in topical cannabidiol: An examination of online search trends from 2015 to 2019
Summary: This study explored the trends in consumer interest for topical CBD products by querying a popular online search engine database from 2015 to 2019 to offer valuable insights. Read the full study here
A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars.
Summary: This study investigates the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their outcome scars.
Read the full study here 
Can CBD Help Your Complexion?
Summary: This article reviews whether CBD protects, heals, and restores your skin.
Read the full study here.

Cannabinoids, Endocannabinoids and Sleep
Summary: A long-term study of sleep quality assessed CBD actions using a common self-report instrument found a modest improvement in sleep, and more patients with improved sleep compared to poorer sleep.
Read the full study here

The use of cannabinoids for sleep: A critical review on clinical trials
Summary: This article reviews clinical studies focused on the effects of cannabinoids on sleep. Many of the reviewed studies suggested that cannabinoids may improve sleep quality, decrease sleep disturbances, and decrease sleep onset times.
Read your full study here

Cannabidiol in Anxiety and Sleep: A Large Case Series
Summary: A clinical case series conducted chart reviews in patients complaining of anxiety and poor sleep. Using cannabidiol (CBD) as an aid, sleep scores increased and anxiety scores decreased within a month in 100/103 patients.
Read the full study here

Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Summary: This study researches the effects of cannabidiol and cannabis on insomnia. It was found that CBD may improve excessive daytime sleepiness and improve sleep among those with chronic pain.
Read the full study here

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial 
Summary: This study uses a randomized, placebo-controlled study design to test the safety and efficacy of CBD on sleep and daytime function in people with insomnia disorder.
Read the full study here

Cannabinoids and Sleep: Helpful or Harmful?
Summary: This review summarizes research evaluating the relationship between cannabinoids and sleep.
Read the full study here

The effects of cannabinoid administration on sleep: a systematic review of human studies
Summary: This paper reviews the literature regarding the effects of cannabinoid administration on sleep in humans. Findings were mixed and showed various effects of cannabinoid administration on several aspects of sleep.
Read the full study here

CBD for Sleep
Summary: Survey demographics and results of using CBD for sleeping problems.
Read the full study here 

 

Delta-8 THC has quickly been on the rise in the cannabis world, and we have compiled a list of scholarly articles to help you better understand the effects and benefits of this cousin of Delta-9 THC.
The Cannabinoids Δ 8 THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation
Summary: This study’s purpose was to investigate the antinociceptive and anti-inflammatory effects of cannabinoids with reported actions at cannabinoid 1 (CB1R) and cannabinoid 2 (CB2R) receptors and/or non-cannabinoid receptors in an experimental model of corneal hyperalgesia.
Read the full study here
Delta-8- and delta-9-tetrahydrocannabinol; Comparison in man by oral and intravenous administration
Summary: This study compares delta 8 and delta 9 tetrahydrocannabinol by oral and intravenous administration in the human body.
Read the full study here